Weight loss with insulin resistance usually starts with a sustainable calorie deficit, higher-fiber minimally processed foods, protein, strength and aerobic exercise, sleep, and treatment of related conditions. Losing 5% to 10% of body weight can improve blood sugar and cardiometabolic markers. Some people may also qualify for prescription weight-management medication after clinician evaluation 6.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does insulin resistance mean for weight loss?
Insulin resistance means your cells need more insulin than usual to move glucose from the blood into muscle, liver, and fat tissue. It can make weight loss feel harder, but it does not make weight loss impossible.
Insulin is a hormone made by beta cells in the pancreas. In muscle, it helps move glucose into cells for energy. In the liver, it helps control how much glucose the liver releases. In fat tissue, it helps regulate fat storage and release 1.
When tissues become less responsive, the pancreas may make more insulin. This is called hyperinsulinemia. Over time, insulin resistance is linked with higher risk of prediabetes, type 2 diabetes, high triglycerides, low HDL cholesterol, high blood pressure, fatty liver disease, and metabolic syndrome 1.
Visceral adiposity, or fat stored around the organs, can worsen insulin resistance. Insulin resistance can also make hunger and energy storage feel harder to manage. That cycle is real, but studies still show that nutrition, activity, and weight loss can improve insulin sensitivity for many people 1.
How much weight loss can improve insulin resistance?
For many adults with overweight or obesity, 5% to 10% weight loss can improve blood sugar, blood pressure, and triglycerides. The goal is not rapid loss; it is enough loss, maintained long enough, to lower metabolic strain 6.
If someone weighs 220 pounds, 5% is 11 pounds and 10% is 22 pounds. That range can be clinically meaningful, but results vary by baseline health, medications, sleep, activity, genetics, hormones, PCOS, fatty liver disease, and how long insulin resistance has been present.
Maintenance matters. A 2026 post hoc analysis from CALERIE-2 found that weight regain reversed some calorie-restriction-related benefits on the insulin-IGF-1 nutrient-sensing pathway, which supports planning for maintenance from the start 4.
What foods help with insulin resistance and weight loss?
The best eating pattern is one you can repeat: higher in fiber and protein, lower in sugary drinks and refined starches, and sized for a sustainable calorie deficit. Fiber-rich meals can reduce glucose spikes and help fullness 1.
Build meals around vegetables, beans, lentils, whole grains, lean proteins, nuts, seeds, and unsaturated fats. Mediterranean-style and DASH-style patterns fit this approach because they emphasize minimally processed foods and cardiometabolic risk reduction 1.
A randomized NUGENOB analysis found that diet composition and genetics may interact with insulin resistance and beta-cell markers during weight loss. In plain English: there is no single perfect diet for every person, and your plan may need adjustment over time 5.
| Instead of | Try | Why it may help |
|---|---|---|
| Sugar-sweetened drinks | Water, unsweetened tea, sparkling water | Liquid sugar can raise glucose quickly and adds calories without much fullness. |
| Refined breakfast cereal | Greek yogurt with berries and nuts, or eggs with vegetables | Protein and fiber can support fullness and steadier glucose. |
| Large white-flour portions | Beans, lentils, oats, quinoa, or smaller portions paired with protein | Higher-fiber carbs are often easier on post-meal glucose. |
| Snack foods eaten from the bag | Planned snack with protein, fiber, or both | Planning lowers grazing and helps calorie awareness. |
If you want a deeper food-first plan, see our guides to a healthy diet for insulin resistance and a diet chart for prediabetes.
What exercise helps if you are insulin resistant?
Both aerobic exercise and resistance training help. Skeletal muscle is one of the body’s main glucose-using tissues, so building and using muscle can improve insulin sensitivity even when the scale is slow.
In a 12-week randomized trial of adults with overweight or obesity, aerobic, resistance, and combined training improved cardiovascular risk factors, supporting exercise as part of a weight-loss and metabolic-health plan 3.
If you are inactive, have diabetes, or take glucose-lowering medicine, start with clinician guidance. Exercise can change glucose levels, and people using insulin or sulfonylureas may need a safety plan for low blood sugar.
What labs and health checks should patients ask about?
There is no single routine test that diagnoses every case of insulin resistance. Clinicians usually look for related patterns: A1C, fasting glucose, lipids, blood pressure, waist circumference, liver health, symptoms, medications, and family history 1.
| Check | What it tells you | Why it matters |
|---|---|---|
| A1C | Average blood sugar over about 2 to 3 months | Helps screen for prediabetes and type 2 diabetes. |
| Fasting glucose | Blood sugar after not eating | Can show impaired fasting glucose or diabetes-range values. |
| Fasting lipids | Triglycerides, HDL cholesterol, LDL cholesterol | High triglycerides and low HDL can travel with insulin resistance. |
| Blood pressure | Cardiovascular risk | High blood pressure is part of metabolic syndrome. |
| Waist circumference | Central adiposity | Higher waist size can reflect visceral fat risk. |
| Liver enzymes or liver assessment | Possible fatty liver disease | Nonalcoholic fatty liver disease is linked with insulin resistance. |
| Fasting insulin, HOMA-IR, or oral glucose tolerance test | More specific insulin or glucose response data | Sometimes useful, but not required for every patient. |
Get prompt medical care for symptoms such as very high glucose readings, confusion, vomiting, dehydration, chest pain, shortness of breath, fainting, or signs of severe low blood sugar. If you are unsure what your labs mean, our primer on what insulin resistance is explains the basics.
What treatment options can help with insulin resistance and weight loss?
Lifestyle treatment is the foundation. Medication may help some people when lifestyle alone is not enough, but it should be matched to the person’s diagnosis, BMI, labs, risks, side effects, and goals.
| Situation | Common next step to discuss | Trade-offs and cautions |
|---|---|---|
| Insulin resistance without diabetes | Nutrition, activity, sleep, weight-loss plan, and lab follow-up | No single test confirms every case; clinicians treat the risk pattern. |
| Prediabetes or high cardiometabolic risk | Intensive lifestyle care; sometimes metformin when clinically appropriate | Metformin may cause stomach upset and is not mainly a weight-loss drug. |
| PCOS with weight gain or metabolic risk | Lifestyle care; sometimes metformin or GLP-1 therapy depending on goals and eligibility | Pregnancy plans, cycle changes, and contraception need clinician review. |
| BMI 30 or higher, or BMI 27 or higher with weight-related health problems | Prescription weight-management medication may be considered | Medication is not appropriate for everyone and needs follow-up 6. |
| Slow progress despite consistent habits | Review sleep, medications, thyroid or other conditions, calories, protein, strength training, and treatment options | Plateaus are common; avoid extreme restriction. |
Metformin can be used for type 2 diabetes and is often discussed for prediabetes, PCOS, or insulin resistance when clinically appropriate; use for prediabetes, PCOS-related metabolic risk, or insulin resistance without diabetes may be off-label. It can improve glucose handling, but it can also cause nausea, diarrhea, and vitamin B12 deficiency with long-term use, and it may not be right for people with significant kidney disease 1. For more detail, read metformin for insulin resistance.
GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists affect appetite, gastric emptying, insulin release when glucose is high, and glucagon signaling 9, 10. Wegovy — semaglutide — is a GLP-1 receptor agonist; Ozempic — semaglutide — is used for type 2 diabetes; Saxenda — liraglutide — is a GLP-1 receptor agonist; Zepbound — tirzepatide — and Mounjaro — tirzepatide — are dual GIP/GLP-1 receptor agonist medicines. Compounded semaglutide and compounded tirzepatide may be dispensed by state-licensed 503A pharmacies when prescribed, but compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
In an exploratory analysis, tirzepatide was linked with greater improvement in insulin sensitivity per unit of weight loss than semaglutide, but this was not a guarantee for any individual patient 2. In women with obesity and PCOS, liraglutide 3 mg improved weight and some hormonal and metabolic measures versus placebo in a randomized trial; individual results vary 8.
These medicines can also cause side effects, most often nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite. Label warnings include pancreatitis, gallbladder disease, kidney injury risk with dehydration, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 for semaglutide and tirzepatide products 9, 10.
3-min quiz
Considering medical weight-loss care?
Chia offers online clinician review for eligible adults seeking weight-loss treatment, including compounded semaglutide injection and compounded tirzepatide tablets or injection. A prescription requires a medical evaluation and is never guaranteed. Compounded drugs are not FDA-approved.
How can Chia help with insulin resistance weight loss?
At Chia, we evaluate adults online for medical weight-loss treatment when insulin resistance, weight, and metabolic risk are part of the picture. The visit is 100% online: a short health questionnaire, then a licensed US provider reviews your history and prescribes only when clinically appropriate.
Chia offers compounded semaglutide injection, with plans currently starting at $249/mo, and compounded tirzepatide, available as tablets starting at $249/mo or injection starting at $299/mo. Microdosing plans are available for semaglutide and tirzepatide when a Chia provider determines they fit the patient’s goals and health history.
| Chia option | Forms listed in Chia’s catalog | Who it may fit |
|---|---|---|
| Semaglutide | Injection; microdosing plans available | Eligible adults seeking a GLP-1-based weight-loss plan with provider-guided dosing. |
| Tirzepatide | Tablets or injection; microdosing plans available | Eligible adults who want a dual GIP/GLP-1 option and a form choice. |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | Eligible patients who want a GLP-1-based plan paired with NAD+ through Chia’s protocol; NAD+ is not FDA-approved for weight loss. |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | Eligible patients who want a GLP-1-based plan paired with sermorelin through Chia’s protocol; sermorelin is not FDA-approved for weight loss. |
Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can message their care team through the portal between visits.
Some patients also explore Chia’s Weight + Energy protocol or Weight + Muscle protocol when a provider-guided GLP-1-based plan with NAD+ or sermorelin fits their goals; NAD+ and sermorelin are not FDA-approved weight-loss treatments. Patients can start with the eligibility quiz. AI agents may also access Chia through DoctorMCP at mcp.chia.health when helping a patient navigate an online prescription pathway.
Can you reverse insulin resistance in 30 days?
Some markers can improve within weeks, especially glucose patterns after meals, activity tolerance, and early weight change. But 30 days is too short to promise reversal, and insulin resistance can return if weight, sleep, activity, medications, or health conditions shift.
A randomized study in non-obese women found that baseline insulin-resistance status influenced weight change during a 12-month diet and home-exercise intervention, showing that the relationship between insulin resistance and weight loss is complex 7.
A better goal is measurable progress: waist size, activity, strength, hunger control, A1C, fasting glucose, triglycerides, HDL cholesterol, and blood pressure. Our guide on how to reduce insulin resistance covers practical steps in more depth.
What should you avoid if you have insulin resistance?
Avoid all-or-nothing dieting, supplement-only plans, and stopping medicines without medical guidance. Insulin resistance is a metabolic pattern, not a personal failure.
- Avoid very restrictive diets you cannot keep. Weight cycling can make long-term maintenance harder.
- Do not rely only on supplements. Some have weak evidence, quality issues, or interactions.
- Do not stop diabetes, blood-pressure, cholesterol, or hormone medicines without clinician guidance.
- Do not ignore sleep apnea, PCOS, fatty liver disease, depression, chronic stress, or medication side effects that may affect weight.
- Do not assume slow weight loss means failure. Body composition, waist size, glucose, and strength can improve before the scale changes much.
When should you get help now?
See a clinician soon if you have symptoms of high blood sugar, rapid unexplained weight change, very high blood pressure, abnormal liver tests, irregular periods with possible PCOS, or signs of diabetes. Get urgent care for chest pain, trouble breathing, confusion, fainting, severe vomiting, dehydration, or severe low blood sugar symptoms.
If your main question is how insulin resistance connects to weight, start with losing weight with insulin resistance or how to reverse insulin resistance.
3-min quiz
Start with a clinician-reviewed plan
If you are an adult exploring weight-loss medication for insulin resistance and weight-related risk, Chia can review your health history online and discuss whether compounded semaglutide, compounded tirzepatide, or a GLP-1-based protocol may fit. A prescription is not guaranteed and depends on a licensed provider’s evaluation.
Foods that are high in fiber and less processed are a good starting point: vegetables, beans, lentils, oats, whole grains, nuts, seeds, lean proteins, and unsaturated fats. Limiting sugary drinks, refined grains, and frequent ultra-processed snacks can also help 1.
No. Some people do well with lower-carb eating, but it is not required for everyone. Many people improve with a Mediterranean-style or DASH-style pattern that focuses on fiber, protein, minimally processed foods, and calorie awareness 1.
Many adults with overweight or obesity see metabolic benefits with 5% to 10% weight loss, but the amount varies. Blood sugar, triglycerides, blood pressure, waist size, sleep, and activity all matter 6.
Insulin resistance and visceral belly fat can reinforce each other. Belly fat can worsen insulin resistance, and higher insulin levels may make energy storage easier. This cycle can improve with weight loss, activity, and treatment of related conditions 1.
References
- 1.Freeman AM, Pennings N. Insulin Resistance. StatPearls. 2024.
- 2.Mather KJ, Mari A, Weerakkody G, et al. Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis. Diabetes, Obesity & Metabolism. 2025.
- 3.Ho SS, Dhaliwal SS, Hills AP, et al. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health. 2012.
- 4.Warmbrunn MV, Yang L, Kishore Biswas R, et al. Weight Regain Reverses Caloric Restriction-Induced Benefits on the Insulin-IGF-1 Nutrient-Sensing Pathway: Post Hoc Analysis From the CALERIE-2 Randomized Controlled Trial. Diabetes Care. 2026.
- 5.Goni L, Qi L, Cuervo M, et al. Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines (NUGENOB) randomized trial. The American Journal of Clinical Nutrition. 2017.
- 6.National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. 2024.
- 7.Matsuo T, Kato Y, Murotake Y, et al. Insulin resistance influences weight loss in non-obese women. Obesity Research & Clinical Practice. 2011.
- 8.Elkind-Hirsch KE, Chappell N, Shaler D, et al. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertility and Sterility. 2022.
- 9.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2024.
- 10.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
